Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resistance to anti-PD1 therapies in patients with advanced melanoma: systematic literature review and application of the Society for Immunotherapy of Cancer Immunotherapy Resistance Taskforce anti-PD1 resistance definitions.
Shui IM, Scherrer E, Frederickson A, Li JW, Mynzhassarova A, Druyts E, Tawbi H. Shui IM, et al. Among authors: druyts e. Melanoma Res. 2022 Dec 1;32(6):393-404. doi: 10.1097/CMR.0000000000000850. Epub 2022 Oct 7. Melanoma Res. 2022. PMID: 36223314
Quality of Life in Wilson's Disease: A Systematic Literature Review.
Balijepalli C, Yan K, Gullapalli L, Barakat S, Chevrou-Severac H, Druyts E. Balijepalli C, et al. Among authors: druyts e. J Health Econ Outcomes Res. 2021 Dec 8;8(2):105-113. doi: 10.36469/jheor.2021.29987. eCollection 2021. J Health Econ Outcomes Res. 2021. PMID: 34963883 Free PMC article.
KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis.
Goulding RE, Chenoweth M, Carter GC, Boye ME, Sheffield KM, John WJ, Leusch MS, Muehlenbein CE, Li L, Jen MH, Rojubally A, Jansen J, Druyts E. Goulding RE, et al. Among authors: druyts e. Cancer Treat Res Commun. 2020;24:100200. doi: 10.1016/j.ctarc.2020.100200. Epub 2020 Jul 25. Cancer Treat Res Commun. 2020. PMID: 32750661 Free article.
81 results